189 related articles for article (PubMed ID: 34685742)
21. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
Eder K; Kalman B
Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
[TBL] [Abstract][Full Text] [Related]
22. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J
Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299
[TBL] [Abstract][Full Text] [Related]
23. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma.
Du J; Ji H; Ma S; Jin J; Mi S; Hou K; Dong J; Wang F; Zhang C; Li Y; Hu S
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33594424
[TBL] [Abstract][Full Text] [Related]
24. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.
Mala U; Baral TK; Somasundaram K
BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717
[TBL] [Abstract][Full Text] [Related]
25. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma.
Yen SY; Chuang HM; Huang MH; Lin SZ; Chiou TW; Harn HJ
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208648
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic modulation of metabolism in glioblastoma.
Dong Z; Cui H
Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139
[TBL] [Abstract][Full Text] [Related]
27. CXCR4-STAT3 Axis Plays a Role in Tumor Cell Infiltration in an Orthotopic Mouse Glioblastoma Model.
Han JH; Yoon JS; Chang DY; Cho KG; Lim J; Kim SS; Suh-Kim H
Mol Cells; 2020 Jun; 43(6):539-550. PubMed ID: 32597394
[TBL] [Abstract][Full Text] [Related]
28. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
29. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
Mukherjee S
Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics analysis of potential core genes for glioblastoma.
Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
[TBL] [Abstract][Full Text] [Related]
31. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
[TBL] [Abstract][Full Text] [Related]
32. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme.
Oberstadt MC; Bien-Möller S; Weitmann K; Herzog S; Hentschel K; Rimmbach C; Vogelgesang S; Balz E; Fink M; Michael H; Zeden JP; Bruckmüller H; Werk AN; Cascorbi I; Hoffmann W; Rosskopf D; Schroeder HW; Kroemer HK
BMC Cancer; 2013 Dec; 13():617. PubMed ID: 24380367
[TBL] [Abstract][Full Text] [Related]
34. Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma.
Alivand MR; Najafi S; Esmaeili S; Rahmanpour D; Zhaleh H; Rahmati Y
Cancer Genet; 2021 Nov; 258-259():135-150. PubMed ID: 34773808
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells in glioblastoma.
Lathia JD; Mack SC; Mulkearns-Hubert EE; Valentim CL; Rich JN
Genes Dev; 2015 Jun; 29(12):1203-17. PubMed ID: 26109046
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme.
Feng L; Qian H; Yu X; Liu K; Xiao T; Zhang C; Kuang M; Cheng S; Li X; Wan J; Zhang K
Sci Rep; 2017 Jul; 7(1):6968. PubMed ID: 28761058
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
Lopez-Bertoni H; Lal B; Michelson N; Guerrero-Cázares H; Quiñones-Hinojosa A; Li Y; Laterra J
Oncogene; 2016 Sep; 35(37):4903-13. PubMed ID: 26898758
[TBL] [Abstract][Full Text] [Related]
39. Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma.
Wen WS; Hu SL; Ai Z; Mou L; Lu JM; Li S
J Cell Physiol; 2017 Dec; 232(12):3622-3630. PubMed ID: 28145562
[TBL] [Abstract][Full Text] [Related]
40. Construction of Novel DNA Methylation-Based Prognostic Model to Predict Survival in Glioblastoma.
Zhao J; Wang L; Kong D; Hu G; Wei B
J Comput Biol; 2020 May; 27(5):718-728. PubMed ID: 31460783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]